HomeCORT • NASDAQ
Corcept Therapeutics Incorporated
$24.31
After Hours:
$24.18
(0.53%)-0.13
Closed: Mar 18, 4:30:52 PM GMT-4 · USD · NASDAQ · Disclaimer
Top gainerStockUS listed securityUS headquartered
Previous close
$23.23
Day range
$23.01 - $25.00
Year range
$20.60 - $34.28
Market cap
2.52B USD
Avg Volume
1.15M
P/E ratio
25.59
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
(USD)Dec 2023Y/Y change
Revenue
135.40M31.39%
Operating expense
101.86M28.81%
Net income
31.36M88.87%
Net profit margin
23.1643.76%
Earnings per share
0.28100.00%
EBITDA
32.24M39.22%
Effective tax rate
14.82%
Total assets
Total liabilities
(USD)Dec 2023Y/Y change
Cash and short-term investments
368.22M-14.70%
Total assets
621.52M6.53%
Total liabilities
114.81M40.72%
Total equity
506.70M
Shares outstanding
103.52M
Price to book
4.74
Return on assets
13.03%
Return on capital
16.34%
Net change in cash
(USD)Dec 2023Y/Y change
Net income
31.36M88.87%
Cash from operations
5.89M-82.37%
Cash from investing
17.10M199.17%
Cash from financing
766.00K1,355.74%
Net change in cash
23.75M47.65%
Free cash flow
2.08M-93.94%
About
Corcept Therapeutics Inc. is a pharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncologic disorders. Corcept has focused on the adverse effects of excess cortisol, studying new compounds that may mitigate those effects. Its executive team is headed by CEO, president and director Joseph K. Belanoff, MD. Wikipedia
Founded
May 13, 1998
Employees
352
Discover more
You may be interested in
This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more
People also search for
Search
Clear search
Close search
Google apps
Main menu